0 NASDAQ Companies - September 23, 2019BeyondSpring’s Plinabulin Continues to Build on Superior Product Profile in Breast Cancer Trial for Neutropenia PreventionRead More
0 NASDAQ Companies - September 23, 2019Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. and Re-Appointment of Andy Sassine to the Board of DirectorsRead More
0 NASDAQ Companies - September 23, 2019Synthorx to Present at the European Society for Medical Oncology (ESMO) 2019 CongressRead More
0 NASDAQ Companies - September 23, 2019ManTech Schedules Third Quarter Fiscal Year 2019 Earnings Release and Conference Call for October 30, 2019Read More
0 NASDAQ Companies - September 23, 2019Celsion Co-sponsors Hepatocellular Carcinoma Symposium at the International Liver Cancer Association (ILCA) Annual ConferenceRead More
0 NASDAQ Companies - September 23, 2019Ebix and Yatra Online, Remain Committed to Creating India’s Leading Travel Services PlatformRead More
0 NASDAQ Companies - September 23, 2019TG Therapeutics Announces Data Presentations at the XVIII International Workshop on Chronic Lymphocytic Leukemia (iwCLL)Read More
0 NASDAQ Companies - September 23, 2019Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019Read More
0 NASDAQ Companies - September 23, 2019Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Funding and Support for ELX-02 U.S. Phase 2 Clinical TrialRead More
